See also this year's filing and all EDGAR filings for this company.
PDF Report 0001481512_2020_Ra_Pharmaceuticals_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001481512, Ra Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 274,694,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,732,000 |
| 3 | remainder_Assets | 4,726,000 |
| 4 | LiabilitiesCurrent | 18,579,000 |
| 5 | LiabilitiesNoncurrent | 3,438,000 |
| 6 | remainder_Liabilities | 21,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 91,776,502 |
| 9 | ResearchAndDevelopmentExpense | 152,570,319 |
| 10 | remainder_Expenses | 1,116 |
| 11 | remainder_Revenues | 2,782,093 |
| 12 | remainder_NetIncome | 9,794,569 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 284,152,000 |
| 1 | Liabilities | 22,038,000 |
| 2 | Expenses | 244,347,937 |
| 3 | Revenues | 2,782,093 |
| 4 | StockholdersEquity | 262,114,000 |
| 5 | NetIncome | -231,771,275 |
| 6 | ComprehensiveNetIncome | -231,771,275 |
| 7 | BaseVar | 281,557,300 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.22 |
| 9 | EconomicCapitalRatio | 3.17 |
Edgar->Model Mapping
Feature Distribution
Change over Time
